Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7027 results

TG Therapeutics takes up option on PI3K-Delta inhibitor, TGR-1202

23-09-2014

US development stage company TG Therapeutics says it has exercised its option to license the global rights…

HematologyLicensingOncologyPharmaceuticalRhizen PharmaceuticalsTG TherapeuticsTGR-1202

Relax intellectual property restrictions in developing markets, urges new CPhI Worldwide report

Relax intellectual property restrictions in developing markets, urges new CPhI Worldwide report

23-09-2014

Pharma must take an evolutionary approach if it wishes to remain sustainable, according to the first…

CPhI WorldwidePharmaceuticalPiramalPiramal HealthcareResearch

Despite limited size, Chile's pharma market offers growing opportunity

23-09-2014

By the end of 2014, the Chilean pharmaceutical market is expected to be worth $2 billion, increasing…

ChileHealthcareMarkets & MarketingPatentsPharmaceuticalRegulation

NovaDel sells ZolpiMist NDA, license and IP to Amherst Pharma

23-09-2014

NovaDel Pharma has sold its insomnia drug ZolpiMist (zolpidem oral spray) New Drug Application to fellow…

Amherst PharmaceuticalsMergers & AcquisitionsNeurologicalNovaDel PharmaPharmaceuticalUSAZolpiMist

OxThera’s Oxabact gains orphan drug designation in EU

OxThera’s Oxabact gains orphan drug designation in EU

23-09-2014

Privately-held Swedish biopharmaceutical company OxThera AB’s product Oxabact (oxalobacter formigenes)…

EUGastro-intestinalsOxabactOxTheraPharmaceuticalRegulationSweden

MMIP formally established to boost medicines manufacturing in the UK

23-09-2014

A new Medicines Manufacturing Industry Partnership (MMIP) has been jointly established by the Association…

ActavisEisaiFujifilm Diosynth BiotechnologiesGlaxoSmithKlineOxford BioMedicaPfizerPharmaceuticalProductionUK

Avillion appoints Jarrod Longcor as chief business officer

Avillion appoints Jarrod Longcor as chief business officer

23-09-2014

UK-based Avillion LLP, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor as…

Avillion LLPBoardroomBosulifPharmaceuticalUK

Russian government mulling restrictions of foreigners in state drug tenders

Russian government mulling restrictions of foreigners in state drug tenders

23-09-2014

The Russian government may take a decision about the imposition of restrictions on the participation…

AsiaMarkets & MarketingPharmaceuticalPoliticsRussia

US Treasury to crack down on tax inversion M&A deals

US Treasury to crack down on tax inversion M&A deals

23-09-2014

The USA’s Department of the Treasury announced on Monday that it is taking action to reduce the tax…

FinancialMergers & AcquisitionsPharmaceuticalPoliticsUSA

IMS Health identifies 10 events that may transform the delivery of health care

IMS Health identifies 10 events that may transform the delivery of health care

23-09-2014

As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalRegulationResearchVaccines

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

22-09-2014

Auxilium Pharmaceuticals’ board of directors, after review of the unsolicited $2.2 billion takeover…

AuxiliumCanadaEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

Russia’s Ozon Pharm to provide facility for Western drug producers

Russia’s Ozon Pharm to provide facility for Western drug producers

22-09-2014

Ozon Pharm, one of Russia’s largest pharmaceutical producers, plans to invest up to 600 million roubles…

FinancialOzon PharmPharmaceuticalProductionRussia

Merck KGaA in $11 billion deal for Sigma-Aldrich

Merck KGaA in $11 billion deal for Sigma-Aldrich

22-09-2014

Germany’s life sciences group Merck KGaA has entered into a definitive agreement to acquire USA-based…

GermanyMerck KGaAMergers & AcquisitionsMilliporePharmaceuticalSigma-Aldrich

Greek pharma trade group SFEE warns on pharma budgets

Greek pharma trade group SFEE warns on pharma budgets

22-09-2014

The members of Greece’s pharma trade group SFEE have called on the government to urgently reset the…

FinancialGreeceLegalPharmaceuticalPricing

Allergy Therapeutics shows increase in revenue in preliminary results

Allergy Therapeutics shows increase in revenue in preliminary results

22-09-2014

UK-based Allergy Therapeutics has announced its preliminary results for the year ended June 30, 2014,…

Allergy TherapeuticsFinancialPharmaceuticalPollinex QuattroRespiratory and PulmonaryUK

Mitsubishi Tanabe Pharma gains approval for Telavic in genotype 2 HCV

Mitsubishi Tanabe Pharma gains approval for Telavic in genotype 2 HCV

22-09-2014

Japanese pharma company Mitsubishi Tanabe Pharma has received approval for an additional indication of…

Anti-viralsJapanMitsubishi TanabePharmaceuticalRegulationTelavic

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

22-09-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, has given notice to CRC European Loan…

AnalgesiaExparelFinancialPacira PharmaceuticalsPharmaceuticalSkyepharmaUKUSA

Europe’s regulatory system for medicines can be used more effectively

Europe’s regulatory system for medicines can be used more effectively

22-09-2014

A new report from Escher, the independent TI Pharma platform for regulatory innovation, shows that the…

Andre BroekmansEuropePharmaceuticalPharmacologyRegulation

Singapore researchers make advance in fighting resistant superbugs

Singapore researchers make advance in fighting resistant superbugs

22-09-2014

A team from Singapore’s A*STAR's Institute of Chemical and Engineering Sciences (ICES) and the National…

Antibiotics and Infectious diseasesMedicinePharmaceuticalResearchSingapore

Bayer’s Eylea approved in Japan for myopic CNV

Bayer’s Eylea approved in Japan for myopic CNV

22-09-2014

Bayer Yakuhin, the Japanese health care subsidiary if Germany’s Bayer has received approval from Japan’s…

BayerEyleaJapanOphthalmicsPharmaceuticalRegeneron PharmaceuticalsRegulation

Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

19-09-2014

Swiss-based iron deficiency specialist Vifor Pharma has appointed Dario Eklund as head of international…

BoardroomHematologyPharmaceuticalSwitzerlandVifor Pharma

1 to 25 of 7027 results

Back to top